Skip to content
2000
image of Impact of the COVID-19 Pandemic on the Clinical Management of People Living with HIV: A Retrospective Study of 246 Patients at a Single Center

Abstract

Introduction

The COVID-19 pandemic caused disruptions in the diagnosis, follow-up and treatment of non-COVID-19 patients due to the burden on the healthcare system. This may lead to missed early diagnosis opportunities in people living with HIV (PLWH). This study aimed to investigate the effects of the COVID-19 pandemic on the demographic characteristics, clinical and laboratory findings, diagnosis, follow-up, and treatment processes of PLWH, and the frequency of opportunistic infections (OIs), AIDS-defining malignancies (ADMs), and late diagnosis (LD).

Methods

In this study, 246 PLWH were identified. During the pandemic period, the mean age of PLWH was lower (=0.025), the use of 2 nucleoside reverse transcriptase inhibitor (NRTI) + protease inhibitor (PI/r) decreased (=0.026) and antiretroviral therapy (ART) adher-ence was higher (=0.015). LD (48.8% . 47.5%) was similar for the two periods, OIs rate (22.6% . 18.5%) was lower and ADMs rate (4.8% . 6.2%) was higher in the pandemic period. Our study was designed as a retrospective cohort study. Individuals over the age of 18 years who were newly diagnosed with HIV infection in our hospital between 2018 and 2023 were included in the study.

Results

During the quarantine period, OIs rate (=0.008) and hospitalization (=0.002) decreased significantly. Compared to the pre-pandemic period, there was a decrease in primary school graduates (=0.043) and Centers for Disease Control and Prevention (CDC) category C applicants (=0.029) and an increase in university graduates (=0.027) in the quarantine period. After the quarantine period, there was an increase in hospitalization (=0.002), CDC category C admissions (=0.021) and ART adherence (=0.016). Other data were similar for the three periods.

Conclusion

In summary, while the COVID-19 pandemic led to notable changes in patients' characteristics and HIV-related clinical characteristics and treatment, the incidence of LD, OIs and ADMs did not increase significantly. Continued monitoring and adaptation of healthcare services are crucial to managing PLWH effectively in the context of global health crises.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/chr/10.2174/011570162X360947250605052248
2025-06-16
2025-10-18

  • From This Site

    /content/journals/chr/10.2174/011570162X360947250605052248
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. Guaraldi G. Borghi V. Milic J. The impact of COVID-19 on UNAIDS 90–90–90 targets: Calls for new HIV care models. Open Forum Infect. Dis. 2021 8 7 ofab283 10.1093/ofid/ofab283 34307725
    [Google Scholar]
  2. Gokengin D. Oprea C. Begovac J. HIV care in Central and Eastern Europe: How close are we to the target? Int. J. Infect. Dis. 2018 70 121 130 10.1016/j.ijid.2018.03.007 29550449
    [Google Scholar]
  3. Ray I. Hasan M.M. Shah P.A. HIV epidemic amidst COVID-19 pandemic in India: A conundrum for the country’s healthcare system. Epidemiol. Infect. 2022 150 e112 10.1017/S095026882200098X 35615920
    [Google Scholar]
  4. Chenneville T. Gabbidon K. Hanson P. Holyfield C. The Impact of COVID-19 on HIV treatment and research: A call to action. Int. J. Environ. Res. Public Health 2020 17 12 4548 10.3390/ijerph17124548 32599783
    [Google Scholar]
  5. Özkaya H.D. Elazab K. Turan B. Missed opportunities in HIV testing in Turkiye: Implications for late diagnoses. J. Acquir. Immune Defic. Syndr. 2024 96 1 77 84 10.1097/QAI.0000000000003398 38346425
    [Google Scholar]
  6. Ambrosioni J. Levi L. Alagaratnam J. Major revision version 12.0 of the European AIDS Clinical Society guidelines 2023. HIV Med. 2023 24 11 1126 1136 10.1111/hiv.13542 37849432
    [Google Scholar]
  7. Quiros-Roldan E Izzo I Carriero C Decrease in new diagnosis of HIV/AIDS in the two years period 2019-2020: Impact of COVID-19 pandemic. J Public Health Res 2022 11 1 jphr.2021.2256 10.4081/jphr.2021.2256 34558252
    [Google Scholar]
  8. Arzu N. Sabri A. Nazlıhan Y. Gamze H. Hividar A. Deniz G. Impact of the COVID-19 pandemic on people newly diagnosed with HIV and those already in -care in Türkiye. Curr. HIV Res. 2024 22 5 290 297 10.2174/011570162X310343240812055718 39162274
    [Google Scholar]
  9. Nalintya E. Sekar P. Kavuma P. Effect of coronavirus disease 2019 lockdowns on identification of advanced human immunodeficiency virus disease in outpatient clinics in Uganda. Clin. Infect. Dis. 2023 76 11 2014 2017 10.1093/cid/ciad087 36799434
    [Google Scholar]
  10. Karaosmanoglu H.K. Mete B. Gunduz A. Changing characteristics of patients living with HIV/AIDS after the COVID-19 pandemic in Turkey. Curr. HIV Res. 2022 20 3 236 241 10.2174/1570162X20666220303103805 35240974
    [Google Scholar]
  11. Evlice O. Başaran S. Şimşek-Yavuz S. Comorbidities, antiretroviral therapy switches, and drug side-effects among HIV-infected patients. Klimik Derg. 2020 33 3 241 247 10.5152/kd.2020.50
    [Google Scholar]
  12. Benli A. Başaran S. Şimşek-Yavuz S. Comparison of antiretroviral treatment regimens used in previously untreated HIV-positive patients in terms of virological response, immunological response and undesirable effects. Klimik Derg. 2018 31 94 100
    [Google Scholar]
  13. Medina N. Alastruey-Izquierdo A. Bonilla O. Impact of the COVID-19 pandemic on HIV care in Guatemala. Int. J. Infect. Dis. 2021 108 422 427 10.1016/j.ijid.2021.06.011 34119676
    [Google Scholar]
  14. Chesney M.A. Factors affecting adherence to antiretroviral therapy. Clin. Infect. Dis. 2000 30 Suppl. 2 S171 S176 10.1086/313849 10860902
    [Google Scholar]
  15. Shorter M.M. Ostermann J. Crump J.A. Characteristics of HIV voluntary counseling and testing clients before and during care and treatment scale-up in Moshi, Tanzania. J. Acquir. Immune Defic. Syndr. 2009 52 5 648 654 10.1097/QAI.0b013e3181b31a6a 19675465
    [Google Scholar]
  16. Mukolo A. Villegas R. Aliyu M. Wallston K.A. Predictors of late presentation for HIV diagnosis: A literature review and suggested way forward. AIDS Behav. 2013 17 1 5 30 10.1007/s10461‑011‑0097‑6 22218723
    [Google Scholar]
  17. Mugusi S.F. Mwita J.C. Francis J.M. Effect of improved access to antiretroviral therapy on clinical characteristics of patients enrolled in the HIV care and treatment clinic, at Muhimbili National Hospital (MNH), Dar es Salaam, Tanzania. BMC Public Health 2010 10 1 291 10.1186/1471‑2458‑10‑291 20509892
    [Google Scholar]
  18. Mocroft A. Lundgren J.D. Sabin M.L. Risk factors and outcomes for late presentation for HIV-positive persons in Europe: Results from the collaboration of observational HIV Epidemiological Research Europe Study (COHERE). PLoS Med. 2013 10 9 e1001510 10.1371/journal.pmed.1001510 24137103
    [Google Scholar]
  19. Zoufaly A. an der Heiden M. Marcus U. Late presentation for HIV diagnosis and care in Germany. HIV Med. 2012 13 3 172 181 10.1111/j.1468‑1293.2011.00958.x 22093171
    [Google Scholar]
  20. Sobrino-Vegas P. Rodríguez-Urrego J. Berenguer J. Educational gradient in HIV diagnosis delay, mortality, antiretroviral treatment initiation and response in a country with universal health care. Antivir. Ther. 2012 17 1 1 8 10.3851/IMP1939 22267463
    [Google Scholar]
  21. Cheng W. Tang W. Han Z. Late presentation of HIV infection: Prevalence trends, and the role of HIV testing strategies in Guangzhou, China, 2008–2013. BioMed Res. Int. 2016 2016 1 7 10.1155/2016/1631878 27761466
    [Google Scholar]
  22. van Bremen K. Monin M. Schlabe S. Impact of COVID‐19 on HIV late diagnosis in a specialized German centre. HIV Med. 2022 23 11 1209 1213 10.1111/hiv.13426 36263724
    [Google Scholar]
  23. Mazzitelli M. Ciccullo A. Baldin G. Has COVID-19 changed the approach to HIV diagnosis? Medicine (Baltimore) 2021 100 41 e27418 10.1097/MD.0000000000027418 34731116
    [Google Scholar]
  24. Hensley K.S. Jordans C.C.E. van Kampen J.J.A. Significant impact of COVID-19 on HIV care in hospitals affecting the first pillar of the HIV care continuum. Clin. Infect. Dis. 2021 74 3 521 524 10.1093/cid/ciab445 33993276
    [Google Scholar]
/content/journals/chr/10.2174/011570162X360947250605052248
Loading
Impact of the COVID-19 Pandemic on the Clinical Management of People Living with HIV: A Retrospective Study of 246 Patients at a Single Center
Bentham Science Publishers ; https://doi.org/10.2174/011570162X360947250605052248
/content/journals/chr/10.2174/011570162X360947250605052248
/content/journals/chr/10.2174/011570162X360947250605052248
Loading

Data & Media loading...


  • Article Type:     Research Article
Keywords: HIV/AIDS ; COVID-19 ; late diagnosis ; opportunistic infection ; people living with HIV ; AIDS-defining malignancies (ADMs)

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test